Terms: = Endocrine gland cancer AND FUBP1, FBP, 8880, ENSG00000162613, FUBP AND Treatment
14 results:
1. Preparation and Performance of Chemotherapy Drug-Loaded Graphene Oxide-Based Nanosheets That Target Ovarian cancer Cells via Folate Receptor Mediation.
Wang J; Han S; Zhang Z; Wang J; Zhang G
J Biomed Nanotechnol; 2021 May; 17(5):960-970. PubMed ID: 34082881
[TBL] [Abstract] [Full Text] [Related]
2. fubp1 mediates the growth and metastasis through TGFβ/Smad signaling in pancreatic adenocarcinoma.
Zhang Y; Chen J; Zhou N; Lu Y; Lu J; Xing X; Chen H; Zhang X
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649780
[TBL] [Abstract] [Full Text] [Related]
3. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.
Debernardi S; O'Brien H; Algahmdi AS; Malats N; Stewart GD; Plješa-Ercegovac M; Costello E; Greenhalf W; Saad A; Roberts R; Ney A; Pereira SP; Kocher HM; Duffy S; Blyuss O; Crnogorac-Jurcevic T
PLoS Med; 2020 Dec; 17(12):e1003489. PubMed ID: 33301466
[TBL] [Abstract] [Full Text] [Related]
4. In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination.
Mandili G; Curcio C; Bulfamante S; Follia L; Ferrero G; Mazza E; Principe M; Cordero F; Satolli MA; Spadi R; Evangelista A; Giordano D; Viet D; Cappello P; Novelli F
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33115943
[TBL] [Abstract] [Full Text] [Related]
5. Long non-coding RNA small nucleolar RNA host gene 6 aggravates pancreatic cancer through upregulation of far upstream element binding protein 1 by sponging microRNA-26a-5p.
Zhang XX; Chen H; Li HY; Chen R; He L; Yang JL; Xiao LL; Chen JL
Chin Med J (Engl); 2020 May; 133(10):1211-1220. PubMed ID: 32433053
[TBL] [Abstract] [Full Text] [Related]
6. Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.
Brown TA; Byrd K; Vreeland TJ; Clifton GT; Jackson DO; Hale DF; Herbert GS; Myers JW; Greene JM; Berry JS; Martin J; Elkas JC; Conrads TP; Darcy KM; Hamilton CA; Maxwel GL; Peoples GE
Cancer Med; 2019 Aug; 8(10):4678-4687. PubMed ID: 31274231
[TBL] [Abstract] [Full Text] [Related]
7. Far upstream element-binding protein 1 is up-regulated in pancreatic cancer and modulates immune response by increasing programmed death ligand 1.
Fan P; Ma J; Jin X
Biochem Biophys Res Commun; 2018 Nov; 505(3):830-836. PubMed ID: 30301530
[TBL] [Abstract] [Full Text] [Related]
8. MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer.
Pénzváltó Z; Lánczky A; Lénárt J; Meggyesházi N; Krenács T; Szoboszlai N; Denkert C; Pete I; Győrffy B
BMC Cancer; 2014 Nov; 14():837. PubMed ID: 25408231
[TBL] [Abstract] [Full Text] [Related]
9. Masked volume wise Principal Component Analysis of small adrenocortical tumours in dynamic [11C]-metomidate Positron Emission Tomography.
Razifar P; Hennings J; Monazzam A; Hellman P; Långström B; Sundin A
BMC Med Imaging; 2009 Apr; 9():6. PubMed ID: 19386097
[TBL] [Abstract] [Full Text] [Related]
10. Bispecific antibody-mediated lysis of primary cultures of ovarian carcinoma cells using multiple target antigens.
Smans KA; Ingvarsson MB; Lindgren P; Canevari S; Walt H; Stigbrand T; Bäckström T; Millán JL
Int J Cancer; 1999 Oct; 83(2):270-7. PubMed ID: 10471538
[TBL] [Abstract] [Full Text] [Related]
11. Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patients.
Luiten RM; Warnaar SO; Sanborn D; Lamers CH; Bolhuis RL; Litvinov SV; Zurawski VR; Coney LR
J Immunother; 1997 Nov; 20(6):496-504. PubMed ID: 9409456
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of folate binding protein in ovarian cancers.
Toffoli G; Cernigoi C; Russo A; Gallo A; Bagnoli M; Boiocchi M
Int J Cancer; 1997 Apr; 74(2):193-8. PubMed ID: 9133455
[TBL] [Abstract] [Full Text] [Related]
13. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.
Mazzoni A; Mezzanzanica D; Jung G; Wolf H; Colnaghi MI; Canevari S
Cancer Res; 1996 Dec; 56(23):5443-9. PubMed ID: 8968099
[TBL] [Abstract] [Full Text] [Related]
14. Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo.
Bottero F; Tomassetti A; Canevari S; Miotti S; Ménard S; Colnaghi MI
Cancer Res; 1993 Dec; 53(23):5791-6. PubMed ID: 8242637
[TBL] [Abstract] [Full Text] [Related]
